Imaging trend and disease course in admitted COVID-19 patients

References

1. ↵
   1. Zhai P,
   2. Ding Y,
   3. Wu X,
   4. Long J,
   5. Zhong Y,
   6. Li Y

   (2020) The epidemiology diagnosis and treatment of COVID-19. Int J Antimicrob Agents 55:105955.

   OpenUrlPubMed
2. ↵
   1. Ahn DG,
   2. Shin HJ,
   3. Kim MH,
   4. Lee S,
   5. Kim HS,
   6. Myoung J,
   7. et al.

   (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol 30:313–24.

   OpenUrlPubMed
3. ↵
   1. Wu YC,
   2. Chen CS,
   3. Chan YJ

   (2020) The outbreak of COVID-19:an overview. J Chin Med Assoc 83:217–220.

   OpenUrlCrossRefPubMed
4. 1. Lauer SA,
   2. Grantz KH,
   3. Bi Q,
   4. Jones FK,
   5. Zheng Q,
   6. Meredith HR,
   7. et al.

   (2020) The incubation period of Coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases:estimation and application. Ann Intern Med 172:577–582.

   OpenUrlCrossRefPubMed
5. ↵
   1. Rothan HA,
   2. Byrareddy SN

   (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433.

   OpenUrlCrossRefPubMed
6. ↵
   1. Li C,
   2. Zhao C,
   3. Bao J,
   4. Tang B,
   5. Wang Y,
   6. Gu B

   (2020) Laboratory diagnosis of coronavirus disease-2019 (COVID-19). Clin Chim Acta 510:35–46.

   OpenUrl
7. ↵
   1. Tang YW,
   2. Schmitz JE,
   3. Persing DH,
   4. Stratton CW

   (2020) Laboratory diagnosis of COVID-19:current issues and challenges. J Clin Microbiol 58:E00512–E00520.

   OpenUrl
8. ↵
   1. Randolph HE,
   2. Barreiro LB

   (2020) Herd immunity:understanding COVID-19. Immunity 52:737–741.

   OpenUrlCrossRefPubMed
9. ↵
   1. Kwok KO,
   2. Lai F,
   3. Wei WI,
   4. Wong SY,
   5. Tang JW

   (2020) Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect 80:E32–E33.

   OpenUrl
10. ↵
    1. Chen J,
    2. Ye L,
    3. Zhou MY,
    4. Cheng YR,
    5. Wang MW,
    6. Feng ZH

    (2020) Herd immunity and COVID-19. Eur Rev Med Pharmacol Sci 24:4064–4065.

    OpenUrl
11. ↵
    1. Hosseiny M,
    2. Kooraki S,
    3. Gholamrezanezhad A,
    4. Reddy S,
    5. Myers L

    (2020) Radiology perspective of Coronavirus disease 2019 (COVID-19):Lessons from severe acute respiratory syndrome and Middle East respiratory syndrome. AJR Am J Roentgenol 214:1078–1082.

    OpenUrlCrossRefPubMed
12. ↵
    1. Liu H,
    2. Liu F,
    3. Li J,
    4. Zhang T,
    5. Wang D,
    6. Lan W

    (2020) Clinical and CT imaging features of the COVID-19 pneumonia:focus on pregnant women and children. J Infect 80:E7–E13.

    OpenUrl
13. ↵
    1. Bai HX,
    2. Hsieh B,
    3. Xiong Z,
    4. Halsey K,
    5. Choi JW,
    6. Tran TM,
    7. et al.

    (2020) Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 296:E46–E54.

    OpenUrlPubMed
14. ↵
    1. Shi H,
    2. Han X,
    3. Jiang N,
    4. Cao Y,
    5. Alwalid O,
    6. Gu J,
    7. et al.

    (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China:a descriptive study. Lancet Infect Dis 20:P425–P434.

    OpenUrl
15. ↵
    1. Lomoro P,
    2. Verde F,
    3. Zerboni F,
    4. Simonetti I,
    5. Borghi C,
    6. Fachinetti C,
    7. et al.

    (2020) COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT:single-center study and comprehensive radiologic literature review. Eur J Radiol Open 7:100231.

    OpenUrlPubMed
16. ↵
    1. Ye Z,
    2. Zhang Y,
    3. Wang Y,
    4. Huang Z,
    5. Song B

    (2020) Chest CT manifestations of new coronavirus disease 2019 (COVID-19):a pictorial review. Eur Radiol 19:4381–4389.

    OpenUrl
17. ↵
    1. Epidemiology Working Group for NCIP Epidemic Response. Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

    (2020) Zhonghua Liu Xing Bing Xue Za Zhi 41:145–151.

    OpenUrlCrossRefPubMed
18. ↵
    1. Liu Y,
    2. Gayle AA,
    3. Wilder-Smith A,
    4. Rocklöv J

    (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. version 2. J Travel Med 27:taaa021.

    OpenUrlPubMed
19. ↵
    1. Kannan S,
    2. Shaik Syed Ali P,
    3. Sheeza A,
    4. Hemalatha K

    (2020) COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 24:2006–2011.

    OpenUrlCrossRef
20. ↵
    1. Li Y,
    2. Xia L

    (2020) Coronavirus Disease 2019 (COVID-19):role of chest CT in diagnosis and management. AJR Am J Roentgenol 214:1280–1286.

    OpenUrlPubMed
21. ↵
    1. Ai T,
    2. Yang Z,
    3. Hou H,
    4. Zhan C,
    5. Chen C,
    6. Lv W,
    7. et al.

    (2020) Correlation of chest CT and RT-PCR testing in Coronavirus disease 2019 (COVID-19) in China:a report of 1014 cases. Radiology 296:E32–E40.

    OpenUrlCrossRefPubMed
22. ↵
    1. Xia W,
    2. Shao J,
    3. Guo Y,
    4. Peng X,
    5. Li Z,
    6. Hu D

    (2020) Clinical and CT features in pediatric patients with COVID-19 infection:different points from adults. Pediatr Pulmonol 55:1169–1174.

    OpenUrlCrossRefPubMed
23. ↵
    1. Bernheim A,
    2. Mei X,
    3. Huang M,
    4. Yang Y,
    5. Fayad ZA,
    6. Zhang N,
    7. et al.

    (2020) Chest CT findings in Coronavirus disease-19 (COVID-19):relationship to duration of infection. Radiology 295:685–691.

    OpenUrl
24. ↵
    1. Syal K

    (2020) COVID-19:Herd immunity and convalescent plasma transfer therapy. J Med Virol 92:1380–1382.

    OpenUrl
25. ↵
    1. Koyama T,
    2. Weeraratne D,
    3. Snowdon JL,
    4. Parida L

    (2020) Emergence of drift variants that may affect COVID-19 Vaccine development and antibody treatment. Pathogens 9:324.

    OpenUrlCrossRefPubMed